Resources
Plasmid Files

pAcGFP1-C In-Fusion® Ready

Linearized vector for fusing AcGFP1 to the N-terminus of a partner protein.

To see this sequence with restriction sites, features, and translations, please download
 SnapGene or the free  SnapGene Viewer.

pAcGFP1-C In-Fusion Ready Sequence and MappAcGFP1-C In-Fusion Ready.dna
Map and Sequence File   
Sequence Author:  Clontech
Download Free Trial Get SnapGene Viewer

 PciI (3301) ApaLI (2987) BsaI (2372) BstBI (2065) RsrII (1899) BsrDI (1616) PflFI - Tth111I (1501) FspI (1485) EagI (1289) BspDI * - ClaI * (1223) BseRI (1201) SfiI (1158) SexAI * (972) AseI (3366) NdeI (3593) SnaBI (3699) NheI (3950) BmtI (3954) AfeI (3955) AgeI (3959) BstEII (4154) Bpu10I (4164) BssHII (4298) EcoNI (4596) PpuMI (4601) PflMI (4670) BspEI (4689) AflII (4695) End (4711) Start (0) EcoRI (8) BamHI (18) XbaI * (30) BclI * (40) MfeI (133) HincII - HpaI (146) MluI (269) pAcGFP1-C In-Fusion® Ready 4711 bp
PciI  (3301)
1 site
A C A T G T T G T A C A

PciI is inhibited by nonionic detergents.
ApaLI  (2987)
1 site
G T G C A C C A C G T G
BsaI  (2372)
1 site
G G T C T C N C C A G A G N ( N ) 4

Sticky ends from different BsaI sites may not be compatible.
BsaI can be used between 37°C and 50°C.
BstBI  (2065)
1 site
T T C G A A A A G C T T
RsrII  (1899)
1 site
C G G W C C G G C C W G G C

Efficient cleavage requires at least two copies of the RsrII
recognition sequence.
Sticky ends from different RsrII sites may not be compatible.
For full activity, add fresh DTT.
BsrDI  (1616)
1 site
G C A A T G N N C G T T A C

Sticky ends from different BsrDI sites may not be compatible.
PflFI  (1501)
1 site
G A C N N N G T C C T G N N N C A G

The 1-base overhangs produced by PflFI may be hard to ligate.
Sticky ends from different PflFI sites may not be compatible.
Tth111I  (1501)
1 site
G A C N N N G T C C T G N N N C A G

The 1-base overhangs produced by Tth111I may be hard to ligate.
Sticky ends from different Tth111I sites may not be compatible.
FspI  (1485)
1 site
T G C G C A A C G C G T
EagI  (1289)
1 site
C G G C C G G C C G G C
BspDI  (1223)
1 site
A T C G A T T A G C T A
* Blocked by Dam methylation.
ClaI  (1223)
1 site
A T C G A T T A G C T A
* Blocked by Dam methylation.
BseRI  (1201)
1 site
G A G G A G ( N ) 8 N N C T C C T C ( N ) 8

Sticky ends from different BseRI sites may not be compatible.
BseRI quickly loses activity at 37°C.
Prolonged incubation with BseRI may lead to degradation of the
DNA.
SfiI  (1158)
1 site
G G C C N N N N N G G C C C C G G N N N N N C C G G

Efficient cleavage requires at least two copies of the SfiI
recognition sequence.
Sticky ends from different SfiI sites may not be compatible.
SexAI  (972)
1 site
A C C W G G T T G G W C C A
* Blocked by Dcm methylation.
Sticky ends from different SexAI sites may not be compatible.
AseI  (3366)
1 site
A T T A A T T A A T T A
NdeI  (3593)
1 site
C A T A T G G T A T A C

Prolonged incubation with NdeI may lead to removal of additional
nucleotides.
SnaBI  (3699)
1 site
T A C G T A A T G C A T
NheI  (3950)
1 site
G C T A G C C G A T C G
BmtI  (3954)
1 site
G C T A G C C G A T C G
AfeI  (3955)
1 site
A G C G C T T C G C G A
AgeI  (3959)
1 site
A C C G G T T G G C C A

AgeI quickly loses activity at 37°C, but can be used at 25°C for
long incubations.
BstEII  (4154)
1 site
G G T N A C C C C A N T G G

Sticky ends from different BstEII sites may not be compatible.
BstEII is typically used at 60°C, but is 50% active at 37°C.
Bpu10I  (4164)
1 site
C C T N A G C G G A N T C G

Efficient cleavage requires at least two copies of the Bpu10I
recognition sequence.
This recognition sequence is asymmetric, so ligating sticky ends
generated by Bpu10I will not always regenerate a Bpu10I site.
Sticky ends from different Bpu10I sites may not be compatible.
BssHII  (4298)
1 site
G C G C G C C G C G C G

BssHII is typically used at 50°C, but is 75% active at 37°C.
EcoNI  (4596)
1 site
C C T N N N N N A G G G G A N N N N N T C C

The 1-base overhangs produced by EcoNI may be hard to ligate.
Sticky ends from different EcoNI sites may not be compatible.
PpuMI  (4601)
1 site
R G G W C C Y Y C C W G G R

Sticky ends from different PpuMI sites may not be compatible.
PflMI  (4670)
1 site
C C A N N N N N T G G G G T N N N N N A C C

Sticky ends from different PflMI sites may not be compatible.
BspEI  (4689)
1 site
T C C G G A A G G C C T
AflII  (4695)
1 site
C T T A A G G A A T T C

The sticky ends produced by AflII are hard to ligate.
End  (4711)
0 sites
Start  (0)
0 sites
EcoRI  (8)
1 site
G A A T T C C T T A A G
BamHI  (18)
1 site
G G A T C C C C T A G G

After cleavage, BamHI-HF™ (but not the original BamHI) can
remain bound to DNA and alter its electrophoretic mobility.
XbaI  (30)
1 site
T C T A G A A G A T C T
* Blocked by Dam methylation.
BclI  (40)
1 site
T G A T C A A C T A G T
* Blocked by Dam methylation.
BclI is typically used at 50-55°C, but is 50% active at 37°C.
MfeI  (133)
1 site
C A A T T G G T T A A C
HincII  (146)
1 site
G T Y R A C C A R Y T G
HpaI  (146)
1 site
G T T A A C C A A T T G
MluI  (269)
1 site
A C G C G T T G C G C A
NeoR/KanR
1255 .. 2049  =  795 bp
264 amino acids  =  29.0 kDa
Product: aminoglycoside phosphotransferase from
Tn5
confers resistance to neomycin, kanamycin, and
G418 (Geneticin)
NeoR/KanR
1255 .. 2049  =  795 bp
264 amino acids  =  29.0 kDa
Product: aminoglycoside phosphotransferase from
Tn5
confers resistance to neomycin, kanamycin, and
G418 (Geneticin)
AcGFP1
3972 .. 4688  =  717 bp
239 amino acids  =  26.9 kDa
Product: Aequorea coerulescens GFP
mammalian codon-optimized
AcGFP1
3972 .. 4688  =  717 bp
239 amino acids  =  26.9 kDa
Product: Aequorea coerulescens GFP
mammalian codon-optimized
ori
2657 .. 3245  =  589 bp
high-copy-number ColE1/pMB1/pBR322/pUC origin
of replication
ori
2657 .. 3245  =  589 bp
high-copy-number ColE1/pMB1/pBR322/pUC origin
of replication
f1 ori
275 .. 730  =  456 bp
f1 bacteriophage origin of replication; arrow
indicates direction of (+) strand synthesis
f1 ori
275 .. 730  =  456 bp
f1 bacteriophage origin of replication; arrow
indicates direction of (+) strand synthesis
SV40 promoter
863 .. 1220  =  358 bp
SV40 enhancer and early promoter
SV40 promoter
863 .. 1220  =  358 bp
SV40 enhancer and early promoter
CMV enhancer
3420 .. 3723  =  304 bp
human cytomegalovirus immediate early enhancer
CMV enhancer
3420 .. 3723  =  304 bp
human cytomegalovirus immediate early enhancer
CMV promoter
3724 .. 3927  =  204 bp
human cytomegalovirus (CMV) immediate early
promoter
CMV promoter
3724 .. 3927  =  204 bp
human cytomegalovirus (CMV) immediate early
promoter
SV40 poly(A) signal
147 .. 268  =  122 bp
SV40 polyadenylation signal
SV40 poly(A) signal
147 .. 268  =  122 bp
SV40 polyadenylation signal
AmpR promoter
757 .. 861  =  105 bp
AmpR promoter
757 .. 861  =  105 bp
HSV TK poly(A) signal
2281 .. 2328  =  48 bp
herpesvirus thymidine kinase polyadenylation signal
HSV TK poly(A) signal
2281 .. 2328  =  48 bp
herpesvirus thymidine kinase polyadenylation signal
stop codons
32 .. 42  =  11 bp
stop codons in all three reading frames
stop codons
32 .. 42  =  11 bp
stop codons in all three reading frames
SV40 ori
1071 .. 1206  =  136 bp
SV40 origin of replication
SV40 ori
1071 .. 1206  =  136 bp
SV40 origin of replication
Try SnapGene and create your own beautiful maps

Individual Sequences & Maps

SnapGene offers the fastest and easiest way to plan, visualize, and document your molecular biology procedures.

Priced accessibly so that everyone in your lab can have a license.

Learn More...

SnapGene Viewer is a versatile tool for creating and sharing richly annotated sequence files. It opens many common file formats.

Free! Because there should be no barriers to seeing your data.

Learn More...

The map, notes, and annotations on this page and in the sequence/map file are copyrighted material. This material may be used without restriction by academic, nonprofit, and governmental entities, except that the source must be cited as "www.snapgene.com/resources". Commercial entities must contact GSL Biotech LLC for permission and terms of use.

Copyright © 2016 GSL Biotech LLC | Site Map | Privacy | Legal Disclaimers   Subscribe to Our Newsletter